HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Internationl PLC
Previous close
$25.88
Day range
$25.60 - $27.53
Year range
$17.38 - $28.15
Market cap
1.97B USD
Avg Volume
646.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 122.54M | 46.93% |
Operating expense | 75.75M | 33.38% |
Net income | -8.89M | -135.22% |
Net profit margin | -7.25 | -123.96% |
Earnings per share | -0.12 | -134.29% |
EBITDA | -18.90M | -3,143.32% |
Effective tax rate | 47.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 243.63M | 18.05% |
Total assets | 580.55M | 10.30% |
Total liabilities | 142.12M | 62.45% |
Total equity | 438.44M | — |
Shares outstanding | 72.64M | — |
Price to book | 4.28 | — |
Return on assets | -8.50% | — |
Return on capital | -10.77% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -8.89M | -135.22% |
Cash from operations | 18.77M | 333.99% |
Cash from investing | 65.29M | 538.38% |
Cash from financing | 2.14M | 208.20% |
Net change in cash | 86.20M | 973.05% |
Free cash flow | 496.12K | -86.46% |
About
Founded
2015
Website
Employees
315
